Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Apr 05 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-apr-05-2021-3

Cadila Healthcare Limited has informed the Exchange regarding a press release dated April 05, 2021, titled "Zydus seeks DCGI approval for the use of Pegylated Interferon alpha-2b in treating COVID-19".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases